Authors:
Casterella, PJ
Kereiakes, DJ
Steinhubl, SR
Raymond, RE
Kottke-Marchant, K
Patel, K
Mueller, M
Rosenthal, M
Moliterno, DJ
Teirstein, PS
Citation: Pj. Casterella et al., The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable, CATHET C IN, 54(4), 2001, pp. 497-504
Authors:
Tate, J
Olencki, T
Finke, J
Kottke-Marchant, K
Rybicki, LA
Bukowski, RM
Citation: J. Tate et al., Phase I trial of simultaneously administered GM-CSF and IL-6 in patients with renal-cell carcinoma: Clinical and laboratory effects, ANN ONCOL, 12(5), 2001, pp. 655-659
Authors:
Sagnella, S
Kwok, J
Marchant, RE
Kottke-Marchant, K
Citation: S. Sagnella et al., Shear-induced platelet activation and adhesion on human pulmonary artery endothelial cells seeded onto hydrophilic polymers, J BIOMED MR, 57(3), 2001, pp. 419-431
Authors:
Topol, EJ
McCarthy, J
Gabriel, S
Moliterno, DJ
Rogers, WJ
Newby, LK
Freedman, M
Metivier, J
Cannata, R
O'Donnell, CJ
Kottke-Marchant, K
Murugesan, G
Plow, EF
Stenina, O
Daley, GQ
Citation: Ej. Topol et al., Single nucleotide polymorphisms in multiple novel thrombospondin genes maybe associated with familial premature myocardial infarction, CIRCULATION, 104(22), 2001, pp. 2641-2644
Authors:
Raghavachari, M
Kottke-Marchant, K
Marchant, RE
Citation: M. Raghavachari et al., Determining intramolecular binding sites on surface-bound von Willebrand factor under aqueous conditions, THROMB RES, 98(4), 2000, pp. 351-358
Authors:
Murugesan, G
Rani, MRS
Ransohoff, RM
Marchant, RE
Kottke-Marchant, K
Citation: G. Murugesan et al., Endothelial cell expression of monocyte chemotactic protein-1, tissue factor, and thrombomodulin on hydrophilic plasma polymers, J BIOMED MR, 49(3), 2000, pp. 396-408
Authors:
Steinhubl, SR
Kottke-Marchant, K
Moliterno, DJ
Rosenthal, M
Topol, EJ
Lincoff, AM
Coller, BS
Citation: Sr. Steinhubl et al., Attainment and maintenance of platelet inhibition through standard dosing of abciximab in patients undergoing percutaneous coronary intervention - Response, CIRCULATION, 102(25), 2000, pp. E186-E186
Authors:
Kottke-Marchant, K
Powers, JB
Brooks, L
Kundu, S
Christie, DJ
Citation: K. Kottke-marchant et al., The effect of antiplatelet drugs, heparin, and preanalytical variables on platelet function detected by the platelet function analyzer (PFA-100 (R)), CL APPL T-H, 5(2), 1999, pp. 122-130
Authors:
Siedlecki, CA
Wang, IW
Higashi, JM
Kottke-Marchant, K
Marchant, RE
Citation: Ca. Siedlecki et al., Platelet-derived microparticles on synthetic surfaces observed by atomic force microscopy and fluorescence microscopy, BIOMATERIAL, 20(16), 1999, pp. 1521-1529
Authors:
Steinhubl, SR
Kottke-Marchant, K
Moliterno, DJ
Rosenthal, ML
Godfrey, NK
Coller, BS
Topol, EJ
Lincoff, AM
Citation: Sr. Steinhubl et al., Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention, CIRCULATION, 100(19), 1999, pp. 1977-1982
Citation: Jr. Bartholomew et K. Kottke-marchant, Monitoring anticoagulation therapy in patients with the lupus anticoagulant, JCR-J CLIN, 4(6), 1998, pp. 307-311
Authors:
Mak, KH
Kottke-Marchant, K
Brooks, LM
Topol, EJ
Citation: Kh. Mak et al., In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blockingplatelet function in plasma of patients with heparin-induced thrombocytopenia, THROMB HAEM, 80(6), 1998, pp. 989-993